Average obligated amount per year since period start.
Portion of total contract value already obligated.
Share of total value represented by subawards.
OXIVAX - AOI #28: INFLUENZA VACCINE INNOVATION. ADVANCING METAGENOMIC NEXT-GENERATION SEQUENCING BASED AGNOSTIC DIAGNOSTICS FOR VIRAL PATHOGENS THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO PREPARE THE IND PACKAGE FOR OVX836+SQ ADJUVANT.
Task order obligations
Estimated months remaining until end of performance.
Period of performance
45% of period elapsed
Awardee
OSOSIVAX
UEI: M4YDKJJRJYC7
Loading contract activity data...
Modification ID | Description | Action Date | Obligated Amount | Action Type |
|---|---|---|---|---|
Subaward # | Subawardee | Description | Amount | Action Date |
|---|---|---|---|---|